Restoring the natural shape of life through RNA therapeutics
Location: United States, Washington, Seattle
Total raised: $147.5M
Investors 4
Date | Name | Website |
- | New Enterp... | nea.com |
- | Mission Bi... | missionbio... |
- | Breton Cap... | bretoncapi... |
- | Refactor C... | refactor.c... |
Funding Rounds 2
Date | Series | Amount | Investors |
15.07.2021 | Series B | $112M | - |
08.11.2019 | Series A | $35.5M | New Enterp... |
Mentions in press and media 14
Date | Title | Description | Source |
07.04.2022 | Rona Therapeutics Announces Completion of $33 Million Series... | - Funding from long-term investors to build leading delivery platform and scalable drug discovery en... | en.prnasia... |
16.07.2021 | Shape Therapeutics picks up $112M | Shape Therapeutics has raised $112 million in a Series B co-led by Decheng Capital and Breton Capita... | pitchbook.... |
16.07.2021 | The continued divvying up of the Weinstein Company | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
16.07.2021 | The continued divvying up of the Weinstein Company | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
15.07.2021 | Shape builds out RNA editing tech with a major $112M funding... | Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the lik... | fiercebiot... |
15.07.2021 | Shape Therapeutics Secures $112 Million in Series B Financin... | SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology compan... | marketscre... |
08.11.2019 | Shape Therapeutics raises $35.5M Series A round to develop R... | The company describes its technology, RNAfix, as allowing for direct in vivo targeting and modificat... | medcitynew... |
06.11.2019 | Shape Therapeutics Raises $35.5M in Series A Financing | Shape Therapeutics, Inc., a Seattle, WA-based development-stage biotechnology company focused on RNA... | finsmes.co... |
06.11.2019 | NEA Leads $35.5M Series A for Shape Therapeutics | SEATTLE--(BUSINESS WIRE)--Shape Therapeutics, Inc. (ShapeTx), a development-stage biotechnology comp... | citybizlis... |
02.02.2015 | RNA therapeutics has a new player: Japan/U.S. collab WaVe Th... | Fierce Biotech took a deeper dive: The big idea at WaVe is that Verdine and Wada have constructed a... | medcitynew... |
Show more